These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28213842)

  • 1. Determination of the Porosity of PLGA Microparticles by Tracking Their Sedimentation Velocity Using a Flow Imaging Microscope (FlowCAM).
    Sediq AS; Waasdorp SKD; Nejadnik MR; van Beers MMC; Meulenaar J; Verrijk R; Jiskoot W
    Pharm Res; 2017 May; 34(5):1104-1114. PubMed ID: 28213842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Flow Imaging Microscopy-Based Method Using Mass-to-Volume Ratio to Derive the Porosity of PLGA Microparticles.
    Sediq AS; Waasdorp SKD; Nejadnik MR; van Beers MMC; Meulenaar J; Verrijk R; Jiskoot W
    J Pharm Sci; 2017 Nov; 106(11):3378-3384. PubMed ID: 28755925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-Flow Imaging as a quantitative tool to assess size and agglomeration of PLGA microparticles.
    van Beers MMC; Slooten C; Meulenaar J; Sediq AS; Verrijk R; Jiskoot W
    Eur J Pharm Biopharm; 2017 Aug; 117():91-104. PubMed ID: 28392414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of PLGA microparticles for controlled and local delivery of Neuregulin-1 in traumatic spinal cord injury.
    Santhosh KT; Alizadeh A; Karimi-Abdolrezaee S
    J Control Release; 2017 Sep; 261():147-162. PubMed ID: 28668379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.
    Desai MP; Labhasetwar V; Walter E; Levy RJ; Amidon GL
    Pharm Res; 1997 Nov; 14(11):1568-73. PubMed ID: 9434276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pore structure of poly(d,l-lactide-co-glycolide) microspheres.
    Vay K; Scheler S; Friess W
    Int J Pharm; 2010 Dec; 402(1-2):20-6. PubMed ID: 20883760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
    Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
    Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.
    Chen W; Palazzo A; Hennink WE; Kok RJ
    Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermally processed polymeric microparticles for year-long delivery of dexamethasone.
    Goodfriend AC; Welch TR; Nguyen KT; Johnson RF; Sebastian V; Reddy SV; Forbess J; Nugent A
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():595-600. PubMed ID: 26478349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the biocompatibility of calcium phosphate cement/PLGA microparticle composites.
    Link DP; van den Dolder J; van den Beucken JJ; Cuijpers VM; Wolke JG; Mikos AG; Jansen JA
    J Biomed Mater Res A; 2008 Dec; 87(3):760-9. PubMed ID: 18200545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
    Sweet JL; Pillay V; Choonara YE
    Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs).
    Lee YS; Lim KS; Oh JE; Yoon AR; Joo WS; Kim HS; Yun CO; Kim SW
    J Control Release; 2015 May; 205():128-33. PubMed ID: 25575866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
    Shen J; Choi S; Qu W; Wang Y; Burgess DJ
    J Control Release; 2015 Nov; 218():2-12. PubMed ID: 26423236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous PLGA microparticles formed by "one-step" emulsification for pulmonary drug delivery: The surface morphology and the aerodynamic properties.
    Nishimura S; Takami T; Murakami Y
    Colloids Surf B Biointerfaces; 2017 Nov; 159():318-326. PubMed ID: 28806664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies.
    Gasmi H; Danede F; Siepmann J; Siepmann F
    J Control Release; 2015 Sep; 213():120-127. PubMed ID: 26150116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.